O=C(C(Cc1ccc(Cl)cc1)NS(=O)(=O)c1ccccc1)N1CC[C@@]2(O)CCCC[C@H]2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?